99208-71-6

Basic information

• Product Name: (S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one
• Synonyms: (S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one;(S)-3,3-dimethyltetrahydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one;(7aS)-3,3-dimethyl-hexahydropyrrolo[1,2-c][1,3]oxazol-5-one;EOS-61025;(S)-3,3-Dimethyltetrahydropyrrolo[1,2-c]oxazol-5(1H)-one;(7aS)-3,3-dimethyl-1,6,7,7a-tetrahydropyrrolo[1,2-c][1,3]oxazol-5-one
• CAS NO: 99208-71-6
• Molecular Formula: C₈H₁₃NO₂
• Molecular Weight: 155.19432
• Mol File: 99208-71-6.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 262.2±19.0 °C(Predicted)
• Appearance: /
• Density: 1.15±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -0.70±0.40(Predicted)
• CAS DataBase Reference: (S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one(99208-71-6)
• EPA Substance Registry System: (S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one(99208-71-6)

Safety Data

• Hazardous Substances Data: 99208-71-6(Hazardous Substances Data)

Usage

General Description

(S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one is a chemical compound with the molecular formula C8H11NO2. It is a heterocyclic compound that has a tetrahydropyrrolo[1,2-c]oxazol-5(3H)-one structure. (S)-3,3-DiMethyltetrahydropyrrolo[1,2-c]oxazol-5(3H)-one is a chiral molecule, meaning it exists in two different mirror-image forms (enantiomers). It may have potential uses in pharmaceutical and medicinal chemistry due to its structural features and potential biological activities. However, further research is needed to fully understand its properties and potential applications in various fields.

Upstream product

• 77-76-9 2,2-dimethoxy-propane 
• 17342-08-4 (S)-Pyroglutaminol 
• 116-11-0 2-Methoxypropene 
• 98-79-3 L-Pyroglutamic acid 
• 7149-65-7 ethyl (S)-pyroglutamate 
• 4931-66-2 methyl (S)-pyroglutamate 

Downstream Products

• 156088-45-8 (5S)-1-aza-2,2-dimethyl-7,7-dimethyl-3-oxa-8-oxo-bicyclo[3.3.0]octane 
• 212890-88-5 (S)-(+)-1-aza-3,3-bisbenzyl-8,8-dimethyl-7-oxabicyclo[3.3.0]octan-2-one 
• 627503-43-9 (S)-3,3-bis(2,4,6-trimethylphenylmethyl)-8,8-dimethyl-7-oxa-1-azabicyclo[3.3.0]octan-2-one 
• 627503-45-1 (S)-3,3-bis(2,4,6-triisopropylphenylmethyl)-8,8-dimethyl-7-oxa-1-azabicyclo[3.3.0]octan-2-one 
• 950172-17-5 (5S)-1-aza-2,2-dimethyl-7,7-di(p-chlorobenzyl)-3-oxa-8-oxo-bicyclo[3.3.0]octane 
• 950172-16-4 (5S)-1-aza-2,2-dimethyl-7,7-di(p-fluorobenzyl)-3-oxa-8-oxo-bicyclo[3.3.0]octane 
• 950172-18-6 (5S)-1-aza-2,2-dimethyl-7,7-di(p-methoxybenzyl)-3-oxa-8-oxo-bicyclo[3.3.0]octane 
• 891183-50-9 4,4-dimethyl-L-proline 
• 950172-26-6 (S)-(+)-(N-benzyloxycarbonyl)-(4,4-di(p-chlorobenzyl)pyrrolidin-2-yl)methan-1-ol 
• 950172-25-5 (S)-(+)-(N-benzyloxycarbonyl)-(4,4-di(p-fluorobenzyl)pyrrolidin-2-yl)methan-1-ol 
• 950172-27-7 (S)-(+)-(N-benzyloxycarbonyl)-(4,4-di(p-methoxybenzyl)pyrrolidin-2-yl)methan-1-ol 
• 950172-28-8 2-hydroxymethyl-4,4-bis-naphthalen-1-ylmethyl-pyrrolidine-1-carboxylic acid benzyl ester 
• 950172-32-4 (S)-(+)-(N-benzyloxycarbonyl)-(4,4-di(2,4,6-trimethylbenzyl)pyrrolidin-2-yl)methan-1-ol 

Relevant articles and documents

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

SUBSTITUTED PYRIDINYL-PYRIMIDINES AND THEIR USE AS MEDICAMENTS

The invention relates to new substituted pyridinyl-pyrimidines of formula 1 wherein ring A is a five-membered saturated or unsaturated carbocyclic ring which optionally comprises one, two or three heteroatoms each independently from each other selected from the group N, S and O, wherein R1, R2, R4, R3, R5 and R6 are defined as in claim 1 and wherein ring A is further optionally substituted by one or two further substituents and the pharmaceutically acceptable salts, diastereomers, enantiomers, racemates, hydrates and solvates of the aforementioned compounds.